CapitolMarkets
Congressional trading

Novartis Ag

NVS · Pharmaceutical
Total trades
20
Politicians involved
9
Net flow
$-566K
Conflict-flagged
16 (80%)

Top traders in NVS

Every disclosed trade in NVS

PoliticianSideAmountTrade dateFiledConflict
Lisa C. McClain
Lisa C. McClain
RHouse
SELL$1K-$15KOct 31, 2025Nov 21, 2025Pharmaceutical
Lisa C. McClain
Lisa C. McClain
RHouse
SELL$1K-$15KOct 30, 2025Nov 21, 2025Pharmaceutical
Lisa C. McClain
Lisa C. McClain
RHouse
BUY$1K-$15KOct 30, 2025Nov 21, 2025Pharmaceutical
Lisa C. McClain
Lisa C. McClain
RHouse
SELL$1K-$15KSep 25, 2025Oct 22, 2025Pharmaceutical
Lisa C. McClain
Lisa C. McClain
RHouse
BUY$1K-$15KSep 11, 2025Oct 22, 2025Pharmaceutical
Lisa C. McClain
Lisa C. McClain
RHouse
SELL$1K-$15KJul 22, 2025Aug 13, 2025Pharmaceutical
Lisa C. McClain
Lisa C. McClain
RHouse
BUY$1K-$15KJun 17, 2025Aug 13, 2025Pharmaceutical
Lisa C. McClain
Lisa C. McClain
RHouse
BUY$1K-$15KJun 11, 2025Aug 13, 2025Pharmaceutical
Lisa C. McClain
Lisa C. McClain
RHouse
SELL$1K-$15KJun 10, 2025Aug 13, 2025Pharmaceutical
Lisa C. McClain
Lisa C. McClain
RHouse
BUY$1K-$15KJun 9, 2025Aug 13, 2025Pharmaceutical
George Whitesides
George Whitesides
DHouse
SELL$100K-$250KMar 24, 2025Apr 23, 2025
Sheldon Whitehouse
Sheldon Whitehouse
DSenate
SELL$1K-$15KApr 9, 2024May 20, 2024Pharmaceutical
Sheldon Whitehouse
Sheldon Whitehouse
DSenate
BUY$15K-$50KSep 20, 2023Oct 17, 2023Pharmaceutical
Daniel S. Goldman
Daniel S. Goldman
DHouse
SELL$250K-$500KJul 10, 2023Aug 13, 2023
Thomas R Carper
Thomas R Carper
DSenate
BUY$1K-$15KApr 26, 2023May 1, 2023
Kevin Hern
Kevin Hern
RHouse
SELL$1K-$15KJan 31, 2023Feb 14, 2023Pharmaceutical
John H. Rutherford
John H. Rutherford
RHouse
SELL$1K-$15KMar 16, 2022Apr 19, 2022
Donald S. Beyer Jr.
Donald S. Beyer Jr.
DHouse
SELL$15K-$50KFeb 28, 2022Mar 3, 2022Pharmaceutical
Donald S. Beyer Jr.
Donald S. Beyer Jr.
DHouse
BUY$1K-$15KJan 31, 2022Feb 1, 2022Pharmaceutical
Shelley Moore Capito
Shelley Moore Capito
RSenate
SELL$1K-$15KDec 15, 2021Jan 21, 2022Pharmaceutical
Public record under the STOCK Act. Capitol Markets is a journalism project — not investment advice.